JDD Buzz Series | AI Chatbots in Dermatology
AI Chatbots in dermatologyAre AI chatbots a wave of the future in dermatology? An article in the November Journal of Drugs in Dermatology assessed dermatologists’ attitudes and beliefs toward artificial intelligence chatbots. Chatbot usage has grown in a variety of areas of society in recent years, and ChatGPT’s popularity shows there’s demand. So to what extent do dermatologists think AI chatbots will play a role in …
AI Chatbots in dermatology
Advancing Vitiligo Treatment: Insights on Current and Emerging Therapies by Dr. Rebecca Vasquez
vitiligo patientAt the Skin of Color Update 2024, we had the honor to learn from Dr. Rebecca Vasquez, Associate Professor at UT Southwestern Medical Center, regarding the evolving field of vitiligo management. Vitiligo affects between 0.5% to 2% of the global population, with no racial or gender preference, yet it carries a significant psychological burden for affected individuals.1 Dr. Vasquez emphasized that vi …
vitiligo patient
Understanding Acquired Macular Dermal Hyperpigmentation Disorders
Acquired Macular Dermal HyperpigmentationMacular dermal hyperpigmentation is an umbrella term, explains Dr. Pearl E. Grimes, symposium chair and clinical professor of dermatology at the University of California, Los Angeles. In an interview with Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium, Dr. Grimes outlines the most common types of macular dermal hyperpigmentation and the factors that may be at play …
Acquired Macular Dermal Hyperpigmentation
Friday Pop Quiz 11/22/2024
A 28-year-old female patient presents with the recent onset of lesions on her right forearm, as shown. She notes that her mother has a history of similar lesions and has a history of pernicious anemia. On examination, she has no lesions elsewhere on her body. Which of the following patient factors is most associated with disease progression in the patient’s condition? A. Age B. Family …